1. Home
  2. FOA vs HBIO Comparison

FOA vs HBIO Comparison

Compare FOA & HBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Finance of America Companies Inc.

FOA

Finance of America Companies Inc.

HOLD

Current Price

$14.49

Market Cap

221.6M

Sector

Finance

ML Signal

HOLD

Logo Harvard Bioscience Inc.

HBIO

Harvard Bioscience Inc.

HOLD

Current Price

$7.96

Market Cap

26.5M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
FOA
HBIO
Founded
2013
1901
Country
United States
United States
Employees
N/A
N/A
Industry
Finance Companies
Biotechnology: Laboratory Analytical Instruments
Sector
Finance
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
221.6M
26.5M
IPO Year
2021
2000

Fundamental Metrics

Financial Performance
Metric
FOA
HBIO
Price
$14.49
$7.96
Analyst Decision
Buy
Buy
Analyst Count
2
2
Target Price
★ $26.00
$18.00
AVG Volume (30 Days)
★ 57.2K
16.5K
Earning Date
05-05-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 216.95
N/A
EPS
★ 0.41
N/A
Revenue
★ $497,432,000.00
$116,176,000.00
Revenue This Year
$0.58
$4.77
Revenue Next Year
$6.91
$8.55
P/E Ratio
$35.10
★ N/A
Revenue Growth
★ 47.09
N/A
52 Week Low
$13.73
$0.38
52 Week High
$29.79
$8.40

Technical Indicators

Market Signals
Indicator
FOA
HBIO
Relative Strength Index (RSI) 28.72 59.23
Support Level N/A $5.84
Resistance Level $20.17 $8.19
Average True Range (ATR) 0.63 0.19
MACD 0.12 -0.07
Stochastic Oscillator 22.96 35.29

Price Performance

Historical Comparison
FOA
HBIO

About FOA Finance of America Companies Inc.

Finance of America Companies Inc provides home equity-based financing solutions for modern retirement and offers capital markets and portfolio management capabilities to optimize loan distribution to investors. The Company operates through two segments: Retirement Solutions and Portfolio Management. The Retirement Solutions segment handles loan origination, including HECM and non-agency reverse mortgage loans, generating revenue from origination fees and initial gains, with loans transferred to the Portfolio Management segment. The Portfolio Management segment, which generates the majority of revenue, provides securitization, loan sales, risk management, and asset management services, and earns revenue from net interest income, fair value changes, and servicing-related income.

About HBIO Harvard Bioscience Inc.

Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, products, and services that enable advances in life science applications, including research, drug and therapy discovery, bioproduction, and preclinical testing. The company organizes its product line into two product families: Cellular and Molecular Technologies (CMT) and Preclinical. The CMT product family supports molecular, cellular, organ, and organoid research, as well as bioproduction and in vitro testing, while the Preclinical product family provides products for preclinical research and testing, including data collection and analysis for safety and regulatory compliance. Its geographical segments include the Americas, Europe, Middle East and Africa, and Asia.

Share on Social Networks: